These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11926851)

  • 1. Pharmaceutical manufacturer assistance programs.
    Chisholm MA; DiPiro JT
    Arch Intern Med; 2002 Apr; 162(7):780-4. PubMed ID: 11926851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication assistance programs for uninsured and indigent patients.
    Chisholm MA; Reinhardt BO; Vollenweider LJ; Kendrick BD; DiPiro JT
    Am J Health Syst Pharm; 2000 Jun; 57(12):1131-6. PubMed ID: 10911511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription assistance programs: options for assisting the uninsured and underinsured.
    Turowski RC; Raskay-Bianco MM; Visconti JA
    Hosp Pharm; 1993 Oct; 28(10):948, 951-5, 958-68. PubMed ID: 10129140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S13-7. PubMed ID: 17057055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Medicare modernization act on low-income persons.
    Havrda DE; Omundsen BA; Bender W; Kirkpatrick MA
    Ann Intern Med; 2005 Oct; 143(8):600-8. PubMed ID: 16230727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of medication-assistance programs for medically uninsured patients: one public teaching hospital's experience.
    Viale PH; Mister S
    Clin J Oncol Nurs; 2001; 5(6):247-52. PubMed ID: 11899624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessing patient assistance programs to meet clients' medication needs.
    Williams K
    J Am Acad Nurse Pract; 2000 Jun; 12(6):233-5. PubMed ID: 11930446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient medication assistance program in a rural setting.
    Harmon GN; Lefante J; Roy W; Ashby KH; Jackson D; Barnard D; Smart A; Webber L
    Am J Health Syst Pharm; 2004 Mar; 61(6):603-7. PubMed ID: 15061432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization.
    Burley MH; Daratha KB; Tuttle K; White JR; Wilson M; Armstrong K; McPherson S; Selinger S
    J Manag Care Spec Pharm; 2016 Apr; 22(4):381-7. PubMed ID: 27023691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication access through patient assistance programs.
    Chauncey D; Mullins CD; Tran BV; McNally D; McEwan RN
    Am J Health Syst Pharm; 2006 Jul; 63(13):1254-9. PubMed ID: 16790577
    [No Abstract]   [Full Text] [Related]  

  • 11. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
    Clay P; Vaught E; Glaros A; Mangum S; Hansen D; Lindsey C
    J Manag Care Pharm; 2007; 13(6):506-14. PubMed ID: 17672812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial Eligibility Criteria and Medication Coverage for Independent Charity Patient Assistance Programs.
    Kang SY; Sen A; Bai G; Anderson GF
    JAMA; 2019 Aug; 322(5):422-429. PubMed ID: 31386135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assistance programs available for medications commonly used in transplant patients.
    Chisholm MA; Tackett KL; Kendrick BD; DiPiro JT
    Clin Transplant; 2000 Aug; 14(4 Pt 1):269-81. PubMed ID: 10945196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician customer satisfaction and medication assistance programs from pharmaceutical companies.
    Fogel J
    South Med J; 2009 Feb; 102(2):123-4. PubMed ID: 19139697
    [No Abstract]   [Full Text] [Related]  

  • 15. Ensuring access to prescription medications in the post-ACA healthcare access landscape: the essential role of FQHCs in the safety net for the underinsured.
    Shi L; Wharton MK; Monnette A
    Am J Manag Care; 2018 Mar; 24(5 Suppl):S67-S73. PubMed ID: 29620813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The limitation of good intentions: prescribing medications for the uninsured.
    Sorensen TD; Song J; Westberg SM
    J Health Care Poor Underserved; 2004 May; 15(2):152-60. PubMed ID: 15253369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals.
    Trompeter JM; Havrda DE
    Ann Pharmacother; 2009 Mar; 43(3):469-77. PubMed ID: 19240259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication assistance programs: eligibility and enrollment.
    Speicher G
    Arch Intern Med; 2002 Dec 9-23; 162(22):2629; author reply 2629-30. PubMed ID: 12456236
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?
    Pisu M; Richman J; Allison JJ; Williams OD; Kiefe CI
    South Med J; 2009 Feb; 102(2):139-44. PubMed ID: 19139695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical manufacturer prescription assistance programs: are they worth it?
    Chen JT; Summers KH
    J Manag Care Pharm; 2007 Sep; 13(7):611-3. PubMed ID: 17874869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.